This was the stock's second consecutive day of gains.
In a report released on February 3, Akash Tewari from Jefferies maintained a Buy rating on Regeneron (REGN – Research Report), with a price ...
Baird lowered the firm’s price target on Regeneron (REGN) to $759 from $940 and keeps a Neutral rating on the shares. The firms lower target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
